RAGE: Exacting a toll on the host in response to polymicrobial sepsis and Listeria monocytogenes

por Clynes, Raphael, Herold, Kevan, Schmidt, Ann Marie
Publicado 2007

β-Cell Mass and Type 1 Diabetes: Going, Going, Gone?

por Akirav, Eitan, Kushner, Jake A., Herold, Kevan C.
Publicado 2008

Acute Metabolic Effects of Exenatide in Patients With Type 1 Diabetes With and Without Residual Insulin to Oral and Intravenous Glucose Challenges

por Ghazi, Tara, Rink, Linda, Sherr, Jennifer L., Herold, Kevan C.
Publicado 2014

The Metabolic Progression to Type 1 Diabetes as Indicated by Serial Oral Glucose Tolerance Testing in the Diabetes Prevention Trial–Type 1

por Sosenko, Jay M., Skyler, Jay S., Herold, Kevan C., Palmer, Jerry P.
Publicado 2012

Inducing and Administering Tregs to Treat Human Disease

por Perdigoto, Ana Luisa, Chatenoud, Lucienne, Bluestone, Jeffrey A., Herold, Kevan C.
Publicado 2016

The Deterrence of Rapid Metabolic Decline Within 3 Months After Teplizumab Treatment in Individuals at High Risk for Type 1 Diabetes

por Sims, Emily K., Cuthbertson, David, Herold, Kevan C., Sosenko, Jay M.
Publicado 2021

Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy

por Hughes, Jing, Vudattu, Nalini, Sznol, Mario, Gettinger, Scott, Kluger, Harriet, Lupsa, Beatrice, Herold, Kevan C.
Publicado 2015

Elevated T cell levels in peripheral blood predict poor clinical response following rituximab treatment in new-onset type 1 diabetes

por Linsley, Peter S., Greenbaum, Carla J., Rosasco, Mario, Presnell, Scott, Herold, Kevan C., Dufort, Matthew J.
Publicado 2018

The Receptor for Advanced Glycation End Products (RAGE) Affects T Cell Differentiation in OVA Induced Asthma

por Akirav, Eitan M., Henegariu, Octavian, Preston-Hurlburt, Paula, Schmidt, Ann Marie, Clynes, Raphael, Herold, Kevan C.
Publicado 2014

Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function

por Herold, Kevan C., Gitelman, Stephen E., Gottlieb, Peter A., Knecht, Laura A., Raymond, Ralph, Ramos, Eleanor L.
Publicado 2023

The receptor for advanced glycation endproducts (RAGE) modulates T cell signaling

por Reed, James C., Preston-Hurlburt, Paula, Philbrick, William, Betancur, Gabriel, Korah, Maria, Lucas, Carrie, Herold, Kevan C.
Publicado 2020

RAGE Expression in Human T Cells: A Link between Environmental Factors and Adaptive Immune Responses

por Akirav, Eitan M., Preston-Hurlburt, Paula, Garyu, Justin, Henegariu, Octavian, Clynes, Raphael, Schmidt, Ann Marie, Herold, Kevan C.
Publicado 2012

Incidence of new-onset in-hospital and persistent diabetes in COVID-19 patients: comparison with influenza

por Lu, Justin Y., Wilson, Jack, Hou, Wei, Fleysher, Roman, Herold, Betsy C., Herold, Kevan C., Duong, Tim Q.
Publicado 2023

Rituximab Selectively Suppresses Specific Islet Antibodies

por Yu, Liping, Herold, Kevan, Krause-Steinrauf, Heidi, McGee, Paula L., Bundy, Brian, Pugliese, Alberto, Krischer, Jeff, Eisenbarth, George S.
Publicado 2011

β cell responses to inflammation

por Usmani-Brown, Sahar, Perdigoto, Ana Luisa, Lavoie, Nathalie, Clark, Pamela, Korah, Maria, Rui, Jinxiu, Betancur, Gabriel, Herold, Kevan C.
Publicado 2019

Synergistic Reversal of Type 1 Diabetes in NOD Mice With Anti-CD3 and Interleukin-1 Blockade: Evidence of Improved Immune Regulation

por Ablamunits, Vitaly, Henegariu, Octavian, Hansen, Jakob Bondo, Opare-Addo, Lynn, Preston-Hurlburt, Paula, Santamaria, Pere, Mandrup-Poulsen, Thomas, Herold, Kevan C.
Publicado 2012

Natural mucosal barriers and COVID-19 in children

por Pierce, Carl A., Sy, Sharlene, Galen, Benjamin, Goldstein, Doctor Y., Orner, Erika, Keller, Marla J., Herold, Kevan C., Herold, Betsy C.
Publicado 2021

Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes

por Anderson, Randy L., DiMeglio, Linda A., Mander, Adrian P., Dayan, Colin M., Linsley, Peter S., Herold, Kevan C., Marinac, Marjana, Ahmed, Simi T.
Publicado 2022

Response to "NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng

por Aizenbud, Lilach, Schoenfeld, David A, Caulfield, Jasmine I, Mann, Jacqueline E, Austin, Matthew R, Perdigoto, Ana Luisa, Herold, Kevan C, Kluger, Harriet M
Publicado 2023

Glucose and Inflammation Control Islet Vascular Density and β-Cell Function in NOD Mice: Control of Islet Vasculature and Vascular Endothelial Growth Factor by Glucose

por Akirav, Eitan M., Baquero, Maria-Teresa, Opare-Addo, Lynn W., Akirav, Michael, Galvan, Eva, Kushner, Jake A., Rimm, David L., Herold, Kevan C.
Publicado 2011